Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06515743

Rehabilitation With an Obturator in Maxillary Defects

Comparison of Quality of Life After Rehabilitation With an Obturator in Maxillary Defects Due to COVID-19 Associated Mucormycosis and Oral Cancer.

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Menoufia University · Academic / Other
Sex
All
Age
30 Years – 70 Years
Healthy volunteers

Summary

During the COVID-19 pandemic, there was a lot of reporting of COVID-19-associated mucormycosis cases. Managing this condition posed a new challenge to clinicians. Management includes therapeutic drugs and aggressive surgical debridement. Due to the unpredictability of disease prognosis and the possible recurrence of the disease, rehabilitation with delayed surgical obturators is beneficial for patients. Hence, the current study aimed to evaluate the impact of delayed surgical obturators on quality of life of COVID-19-associated mucormycosis patients post-maxillectomies

Detailed description

Globally, the prevalence of mucormycosis varied from 0.005 to 1.7 per million population, while its prevalence is nearly 80 times higher (0.14 per 1000) in India compared to developed countries, in a recent estimate of year 2019-2020. Among the medical professionals involved in managing patients with mucormycosis, maxillofacial prosthodontists are responsible for prosthetic restoration of lost oral and maxillofacial structures, helping patients to socialize and have an acceptable quality of life after surgical treatment

Conditions

Interventions

TypeNameDescription
OTHERDelayed surgical obturatorProsthetic rehabilitation after surgical treatment of mucormycosis is essential for the early restoration of oral function and facial esthetics which is performed by using the surgical obturator.

Timeline

Start date
2024-02-04
Primary completion
2024-09-20
Completion
2024-11-30
First posted
2024-07-23
Last updated
2024-08-15

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06515743. Inclusion in this directory is not an endorsement.